1. Home
  2. RAPP vs ASST Comparison

RAPP vs ASST Comparison

Compare RAPP & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$27.16

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Logo Asset Entities Inc. Class B

ASST

Asset Entities Inc. Class B

SELL

Current Price

$11.87

Market Cap

998.7M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
RAPP
ASST
Founded
2022
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
998.7M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
RAPP
ASST
Price
$27.16
$11.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$47.00
$30.00
AVG Volume (30 Days)
337.3K
6.1M
Earning Date
03-10-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,512,106.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
125.01
52 Week Low
$6.43
$9.35
52 Week High
$42.27
$157.80

Technical Indicators

Market Signals
Indicator
RAPP
ASST
Relative Strength Index (RSI) 48.33 94.96
Support Level $25.21 $0.49
Resistance Level $28.59 $0.81
Average True Range (ATR) 1.53 0.14
MACD 0.01 0.59
Stochastic Oscillator 52.96 92.78

Price Performance

Historical Comparison
RAPP
ASST

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About ASST Asset Entities Inc. Class B

Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.

Share on Social Networks: